Origin Materials reports Q4 EPS (9c) vs (7c) last year
Reports Q4 revenue $9.2M vs $13.1M last year. “This year was transformational for Origin and Q4 was an inflection point for our caps and ...
The Manila Times8m
Lyra Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
Company continues to focus on upcoming results from ENLIGHTEN 2 pivotal Phase 3 trial in CRS patients, expected in 2Q 2025; In parallel, the Company continues to analyze data and ...
KTVQ3m
Tampa Bay Rays says team will not move forward with $1.3 billion stadium deal
The Tampa Bay Rays announced they will not proceed with a new stadium project, marking the end of a years-long process that the team, city and county thought had been settled last year.
KTVQ47m
Fentanyl crisis sparks advocacy for harm reduction efforts in recovery
For years, individuals battling opioid addiction have faced a grim choice: get clean or die. But some people now see a third option — harm reduction.